Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Proton Rahman

Showing results (121-130 of 260) with videos related to

Pageof 26
Sort By:
The Journal of Rheumatology|October 6, 2005
Interleukin 1 and nuclear factor-kappaB polymorphisms in ankylosing spondylitis in Canada and KoreaTae-Hwan Kim, Millicent A Stone, Proton Rahman, et al.
Rheumatology (Oxford, England)|April 15, 2010
Predictors of response to intra-articular steroid injection in psoriatic arthritisLihi Eder, Vinod Chandran, Joanna Ueng, et al.
Metabolomics : Official Journal of the Metabolomic Society|September 30, 2022
Glutathione, polyamine, and lysophosphatidylcholine synthesis pathways are associated with circulating pro-inflammatory cytokinesMing Liu, Hongwei Zhang, Zikun Xie, et al.
BMC Musculoskeletal Disorders|October 11, 2015
Genome-wide DNA methylation study of hip and knee cartilage reveals embryonic organ and skeletal system morphogenesis as major pathways involved in osteoarthritisErfan Aref-Eshghi, Yuhua Zhang, Ming Liu, et al.
Advances in Therapy|July 22, 2025
Ixekizumab Improves Signs, Symptoms, and Quality of Life in Patients with Axial Spondyloarthritis Irrespective of Symptom DurationVictoria Navarro-Compán, John D Reveille, Proton Rahman, et al.
Annals of the Rheumatic Diseases|April 22, 2016
Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2)Arthur Kavanaugh, Lluis Puig, Alice B Gottlieb, et al.
The Journal of Rheumatology|September 12, 2008
Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitisWalter P Maksymowych, Proton Rahman, Kam Shojania, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 30, 2008
The apolipoprotein E2 isoform is associated with accelerated onset of coronary artery disease in systemic lupus erythematosusAntonio Orlacchio, Ian N Bruce, Proton Rahman, et al.
The Journal of Rheumatology|May 20, 2008
Interleukin 1 polymorphisms in patients with ankylosing spondylitis in KoreaTae-Jong Kim, Tae-Hwan Kim, Hyun-Joo Lee, et al.
Scientific Reports|December 11, 2020
Rho-GTPase pathways may differentiate treatment response to TNF-alpha and IL-17A inhibitors in psoriatic arthritisSara Rahmati, Darren D O'Rielly, Quan Li, et al.
Pageof 26

Showing results (121-130 of 260) with videos related to

Sort By:
Pageof 26
The Journal of Rheumatology|October 6, 2005
Interleukin 1 and nuclear factor-kappaB polymorphisms in ankylosing spondylitis in Canada and KoreaTae-Hwan Kim, Millicent A Stone, Proton Rahman, et al.
Rheumatology (Oxford, England)|April 15, 2010
Predictors of response to intra-articular steroid injection in psoriatic arthritisLihi Eder, Vinod Chandran, Joanna Ueng, et al.
Metabolomics : Official Journal of the Metabolomic Society|September 30, 2022
Glutathione, polyamine, and lysophosphatidylcholine synthesis pathways are associated with circulating pro-inflammatory cytokinesMing Liu, Hongwei Zhang, Zikun Xie, et al.
BMC Musculoskeletal Disorders|October 11, 2015
Genome-wide DNA methylation study of hip and knee cartilage reveals embryonic organ and skeletal system morphogenesis as major pathways involved in osteoarthritisErfan Aref-Eshghi, Yuhua Zhang, Ming Liu, et al.
Advances in Therapy|July 22, 2025
Ixekizumab Improves Signs, Symptoms, and Quality of Life in Patients with Axial Spondyloarthritis Irrespective of Symptom DurationVictoria Navarro-Compán, John D Reveille, Proton Rahman, et al.
Annals of the Rheumatic Diseases|April 22, 2016
Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2)Arthur Kavanaugh, Lluis Puig, Alice B Gottlieb, et al.
The Journal of Rheumatology|September 12, 2008
Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitisWalter P Maksymowych, Proton Rahman, Kam Shojania, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 30, 2008
The apolipoprotein E2 isoform is associated with accelerated onset of coronary artery disease in systemic lupus erythematosusAntonio Orlacchio, Ian N Bruce, Proton Rahman, et al.
The Journal of Rheumatology|May 20, 2008
Interleukin 1 polymorphisms in patients with ankylosing spondylitis in KoreaTae-Jong Kim, Tae-Hwan Kim, Hyun-Joo Lee, et al.
Scientific Reports|December 11, 2020
Rho-GTPase pathways may differentiate treatment response to TNF-alpha and IL-17A inhibitors in psoriatic arthritisSara Rahmati, Darren D O'Rielly, Quan Li, et al.
Pageof 26